Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Brolucizumab as Good as Aflibercept for Neovascular AMDBrolucizumab is noninferior to aflibercept and requires less-frequent injections for patients with neovascular age-related macular degeneration (nAMD), according to results from two phase-3 trials.
FLUID Study Rethinks Treat-and-Extend in Neovascular AMDStudy results show that some subretinal fluid can be tolerated after anti-VEGF injections without sacrificing visual outcomes. Dr Charles Wykoff explains why it may not be that simple.
Medscape Ophthalmology, June 11, 2019
ADA 2019Read clinically focused news coverage of key developments from ADA 2019
